Online Interactive Platform for COVID-19 Literature Visual Analytics: Platform Development Study

Background Papers on COVID-19 are being published at a high rate and concern many different topics. Innovative tools are needed to aid researchers to find patterns in this vast amount of literature to identify subsets of interest in an automated fashion. Objective We present a new online software resource with a friendly user interface that allows users to query and interact with visual representations of relationships between publications. Methods We publicly released an application called PLATIPUS (Publication Literature Analysis and Text Interaction Platform for User Studies) that allows researchers to interact with literature supplied by COVIDScholar via a visual analytics platform. This tool contains standard filtering capabilities based on authors, journals, high-level categories, and various research-specific details via natural language processing and dozens of customizable visualizations that dynamically update from a researcher’s query. Results PLATIPUS is available online and currently links to over 100,000 publications and is still growing. This application has the potential to transform how COVID-19 researchers use public literature to enable their research. Conclusions The PLATIPUS application provides the end user with a variety of ways to search, filter, and visualize over 100,00 COVID-19 publications.

[1]  R. Altman,et al.  Analyzing the vast coronavirus literature with CoronaCentral , 2020, bioRxiv.

[2]  E. Chow,et al.  Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review , 2020, The Journal of Pediatrics.

[3]  S. Dima,et al.  COVID-19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review). , 2020, Experimental and therapeutic medicine.

[4]  S. Vollmer,et al.  Type 2 Diabetes and COVID-19–Related Mortality in the Critical Care Setting: A National Cohort Study in England, March–July 2020 , 2020, Diabetes care.

[5]  T. Sathish,et al.  Is newly diagnosed diabetes a stronger risk factor than pre‐existing diabetes for COVID‐19 severity? , 2020, Journal of diabetes.

[6]  P. Zachariah,et al.  Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings , 2020, The Journal of Pediatrics.

[7]  Joshua Mendoza,et al.  Text-Based Analytics for Biosurveillance , 2018 .

[8]  Jin-Kui Yang,et al.  Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes , 2009, Acta Diabetologica.

[9]  Zhiyong Lu,et al.  LitCovid: an open database of COVID-19 literature , 2020, Nucleic Acids Res..

[10]  Jeffrey Brainard,et al.  Scientists are drowning in COVID-19 papers. Can new tools keep them afloat? , 2020 .

[11]  K. Tsirilakis,et al.  Vaping-Associated Lung Injury During COVID-19 Multisystem Inflammatory Syndrome Outbreak , 2020, The Journal of Emergency Medicine.

[12]  Mimi Y. Kim,et al.  SARS-CoV-2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth , 2020, The Journal of Pediatrics.

[13]  Resul Yılmaz,et al.  Clinical features and outcome of MIS-C patients: an experience from Central Anatolia , 2021, Clinical Rheumatology.

[14]  Gerbrand Ceder,et al.  COVIDScholar: An automated COVID-19 research aggregation and analysis platform , 2020, PloS one.

[15]  M. Kloc,et al.  Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM? , 2020, Journal of Diabetes & Metabolic Disorders.